163 related articles for article (PubMed ID: 26430235)
1. Budesonide-related adrenal insufficiency.
Arntzenius A; van Galen L
BMJ Case Rep; 2015 Oct; 2015():. PubMed ID: 26430235
[TBL] [Abstract][Full Text] [Related]
2. A Case of a Post-Operative Addisonian Crisis from HPA Axis Suppression from Inhaled Corticosteroids.
Allen G; Mitchell A; Ramirez M; Holsten S; Shah N
Am Surg; 2019 Sep; 85(9):e483-e484. PubMed ID: 31638547
[No Abstract] [Full Text] [Related]
3. Severe adrenal insufficiency complicating budesonide therapy for Crohn's disease.
Berkelhammer C; Trabolsi M; Andrejic J; Yasmeen T
Inflamm Bowel Dis; 2011 Apr; 17(4):1053-4. PubMed ID: 20629105
[No Abstract] [Full Text] [Related]
4. Screening for adrenal suppression in children with inflammatory bowel disease discontinuing glucocorticoid therapy.
Sidoroff M; Kolho KL
BMC Gastroenterol; 2014 Mar; 14():51. PubMed ID: 24661924
[TBL] [Abstract][Full Text] [Related]
5. Replacement of conventional glucocorticoids by oral pH-modified release budesonide in active and inactive Crohn's disease: results of an open, prospective, multicenter trial.
Andus T; Gross V; Caesar I; Schulz HJ; Lochs H; Strohm WD; Gierend M; Weber A; Ewe K; Schölmerich J;
Dig Dis Sci; 2003 Feb; 48(2):373-8. PubMed ID: 12643618
[TBL] [Abstract][Full Text] [Related]
6. Iatrogenic adrenal insufficiency as a side-effect of combined treatment of itraconazole and budesonide.
Skov M; Main KM; Sillesen IB; Müller J; Koch C; Lanng S
Eur Respir J; 2002 Jul; 20(1):127-33. PubMed ID: 12166560
[TBL] [Abstract][Full Text] [Related]
7. [Adrenal insufficiency during inhaled corticosteroid treatment in a child with asthma].
Bjerre JV; Bender L; Naeraa RW; Rix M
Ugeskr Laeger; 2008 Jun; 170(24):2161. PubMed ID: 18565305
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic drug evaluation of budesonide in the treatment of Crohn's disease.
Kwapisz L; Jairath V; Khanna R; Feagan B
Expert Opin Drug Metab Toxicol; 2017 Jul; 13(7):793-801. PubMed ID: 28612627
[TBL] [Abstract][Full Text] [Related]
9. Adrenal crisis while on high-dose steroid treatment: what rheumatologist should consider?
Üsküdar Cansu D; Cansu GB; Arik D; Korkmaz C
Rheumatol Int; 2017 Apr; 37(4):657-662. PubMed ID: 27803964
[TBL] [Abstract][Full Text] [Related]
10. Adrenal Suppression in Children Treated With Oral Viscous Budesonide for Eosinophilic Esophagitis.
Harel S; Hursh BE; Chan ES; Avinashi V; Panagiotopoulos C
J Pediatr Gastroenterol Nutr; 2015 Aug; 61(2):190-3. PubMed ID: 25950088
[TBL] [Abstract][Full Text] [Related]
11. Budesonide in Crohn's disease: findings of a compassionate-use program.
Lyckegaard E; Håkansson K; Bengtsson B
Hepatogastroenterology; 2007; 54(79):2024-7. PubMed ID: 18251152
[TBL] [Abstract][Full Text] [Related]
12. [Adrenal cortex suppression attributed to the use of budesonide].
van Heest JA; Bokma JA; van Oudheusden LJ; Stricker BH
Ned Tijdschr Geneeskd; 1994 Oct; 138(44):2204-7. PubMed ID: 7969601
[TBL] [Abstract][Full Text] [Related]
13. Severe hypokaliemia and metabolic alkalosis in a Crohn's disease patient after budesonide treatment: evidence for intestinal secretion of potassium.
Elriz K; Savoye G; Tamion F; Déchelotte P; Lerebours E
Dig Liver Dis; 2008 Feb; 40(2):149-50. PubMed ID: 18082475
[No Abstract] [Full Text] [Related]
14. Safety analysis of long-term budesonide nasal irrigations in patients with chronic rhinosinusitis post endoscopic sinus surgery.
Soudry E; Wang J; Vaezeafshar R; Katznelson L; Hwang PH
Int Forum Allergy Rhinol; 2016 Jun; 6(6):568-72. PubMed ID: 26879335
[TBL] [Abstract][Full Text] [Related]
15. Budesonide in the treatment of Crohn's disease: a meta-analysis.
Papi C; Luchetti R; Gili L; Montanti S; Koch M; Capurso L
Aliment Pharmacol Ther; 2000 Nov; 14(11):1419-28. PubMed ID: 11069312
[TBL] [Abstract][Full Text] [Related]
16. Hypoglycemia as a manifestation of iatrogenic adrenal insufficiency due to topical steroids.
Diéguez Felechosa M; Valdés Gallego N; García-Alcalde Fernández ML; Casal Alvarez F
Endocrinol Nutr; 2013 Nov; 60(9):e21-2. PubMed ID: 24091360
[No Abstract] [Full Text] [Related]
17. Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group.
Greenberg GR; Feagan BG; Martin F; Sutherland LR; Thomson AB; Williams CN; Nilsson LG; Persson T
N Engl J Med; 1994 Sep; 331(13):836-41. PubMed ID: 8078529
[TBL] [Abstract][Full Text] [Related]
18. Adrenal insufficiency secondary to inappropriate oral administration of topical exogenous steroids presenting with hypercalcaemia.
Bhatti RS; Flynn MD
BMJ Case Rep; 2012 Jun; 2012():. PubMed ID: 22729340
[TBL] [Abstract][Full Text] [Related]
19. A successful switch from prednisone to budesonide for neuropsychiatric adverse effects in a patient with ileal Crohn's disease.
Nahon S; Pisanté L; Delas N
Am J Gastroenterol; 2001 Jun; 96(6):1953-4. PubMed ID: 11419871
[No Abstract] [Full Text] [Related]
20. A comparison of budesonide with prednisolone for active Crohn's disease.
Rutgeerts P; Löfberg R; Malchow H; Lamers C; Olaison G; Jewell D; Danielsson A; Goebell H; Thomsen OO; Lorenz-Meyer H
N Engl J Med; 1994 Sep; 331(13):842-5. PubMed ID: 8078530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
